Christophe Rioux

2.6k total citations
9 papers, 495 citations indexed

About

Christophe Rioux is a scholar working on Infectious Diseases, Surgery and Neurology. According to data from OpenAlex, Christophe Rioux has authored 9 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 4 papers in Surgery and 2 papers in Neurology. Recurrent topics in Christophe Rioux's work include Tuberculosis Research and Epidemiology (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Genital Health and Disease (2 papers). Christophe Rioux is often cited by papers focused on Tuberculosis Research and Epidemiology (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Genital Health and Disease (2 papers). Christophe Rioux collaborates with scholars based in France, United States and Vietnam. Christophe Rioux's co-authors include Sylvie Rozenberg, Anne Bissery, E. Zing, Jean‐Louis Golmard, Jean‐Charles Piette, Gisèle Le Moël, Pierre Bourgeois, Bruno Fautrel, Francine Walker and Catherine Leport and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Emerging infectious diseases.

In The Last Decade

Christophe Rioux

8 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christophe Rioux France 7 285 165 153 118 108 9 495
Francesca Minoia Italy 13 466 1.6× 214 1.3× 240 1.6× 34 0.3× 144 1.3× 39 703
Daniela Iacono Italy 11 308 1.1× 96 0.6× 218 1.4× 27 0.2× 102 0.9× 29 449
Ginger Janow United States 8 370 1.3× 149 0.9× 149 1.0× 35 0.3× 140 1.3× 14 493
Fatih Haşlak Türkiye 12 109 0.4× 118 0.7× 99 0.6× 34 0.3× 152 1.4× 59 425
Miroslav Harjaček Croatia 11 162 0.6× 56 0.3× 135 0.9× 45 0.4× 126 1.2× 40 419
Mustafa Çakan Türkiye 14 132 0.5× 159 1.0× 176 1.2× 58 0.5× 302 2.8× 83 590
Dana Němcová Czechia 13 180 0.6× 63 0.4× 80 0.5× 63 0.5× 88 0.8× 37 478
Olive S. Eckstein United States 9 242 0.8× 65 0.4× 162 1.1× 24 0.2× 42 0.4× 29 411
Sebastian Birndt Germany 7 615 2.2× 66 0.4× 479 3.1× 69 0.6× 62 0.6× 10 909
Jasmina Kalabic United States 13 207 0.7× 81 0.5× 177 1.2× 179 1.5× 47 0.4× 68 563

Countries citing papers authored by Christophe Rioux

Since Specialization
Citations

This map shows the geographic impact of Christophe Rioux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Rioux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Rioux more than expected).

Fields of papers citing papers by Christophe Rioux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Rioux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Rioux. The network helps show where Christophe Rioux may publish in the future.

Co-authorship network of co-authors of Christophe Rioux

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Rioux. A scholar is included among the top collaborators of Christophe Rioux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Rioux. Christophe Rioux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Gerussi, Valentina, Thomas Nordahl Petersen, Isabelle Bonnet, et al.. (2025). Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment. Emerging infectious diseases. 31(3). 633–636.
2.
Kherabi, Yousra, et al.. (2022). Patient-centered approach to the management of drug-resistant tuberculosis in France: How far off the mark are we?. SHILAP Revista de lepidopterología. 2(4). e0000313–e0000313. 1 indexed citations
3.
Kherabi, Yousra, Christophe Rioux, Yazdan Yazdanpanah, et al.. (2022). Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006–2019. Emerging infectious diseases. 28(9). 1796–1804. 9 indexed citations
4.
Dubert, Marie, Benoît Visseaux, Valentina Isernia, et al.. (2020). Case report study of the first five COVID-19 patients treated with remdesivir in France. International Journal of Infectious Diseases. 98. 290–293. 25 indexed citations
5.
Isernia, Valentina, Zélie Julia, Sylvie Le Gac, et al.. (2020). SARS-COV2 infection in 30 HIV-infected patients followed-up in a French University Hospital. International Journal of Infectious Diseases. 101. 49–51. 14 indexed citations
6.
Bertin, C., Rachid Abbas, Valérie Andrieu‐Ponel, et al.. (2019). Illicit massive silicone injections always induce chronic and definitive silicone blood diffusion with dermatologic complications. Medicine. 98(4). e14143–e14143. 13 indexed citations
7.
Lafaurie, Matthieu, Nathanaël Lapidus, Michel Daudon, et al.. (2014). Clinical Features and Risk Factors for Atazanavir (ATV)-Associated Urolithiasis: A Case-Control Study. PLoS ONE. 9(11). e112836–e112836. 10 indexed citations
8.
Abramowitz, Laurent, Philippe Ravaud, Francine Walker, et al.. (2007). Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women: prevalence and associated factors. AIDS. 21(11). 1457–1465. 104 indexed citations
9.
Fautrel, Bruno, E. Zing, Jean‐Louis Golmard, et al.. (2002). Proposal for a New Set of Classification Criteria for Adult-Onset Still Disease. Medicine. 81(3). 194–200. 319 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Minoia Breakdown of academic impact, for papers by Daniela Iacono Breakdown of academic impact, for papers by Ginger Janow Breakdown of academic impact, for papers by Fatih Haşlak Breakdown of academic impact, for papers by Miroslav Harjaček Breakdown of academic impact, for papers by Mustafa Çakan Breakdown of academic impact, for papers by Dana Němcová Breakdown of academic impact, for papers by Olive S. Eckstein Breakdown of academic impact, for papers by Sebastian Birndt Breakdown of academic impact, for papers by Jasmina Kalabic
Rankless by CCL
2026